<DOC>
	<DOCNO>NCT01089751</DOCNO>
	<brief_summary>This study investigate safety efficacy Sanctura XR ( trospium chloride ) daily reduce urgency , urinary frequency urinary urge incontinence female patient incontinence refractory Detrol LA ( tolterodine tartrate extend release ) 4 mg therapy .</brief_summary>
	<brief_title>Efficacy Sanctura XR ( Trospium Chloride ) Reducing Overactive Bladder Symptoms Female Subjects Refractory Detrol LA ( Tolterodine Tartrate Extended Release ) Daily</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Trospium chloride</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Taking DetrolÂ® LA 4mg daily minimum 1 month prior Screening/Qualification Overactive Bladder syndrome urgency , urinary frequency urgency urinary incontinence Taking five concomitant medication ( may prescription , nonprescription , supplement/vitamin ) daily indication Overactive Bladder ( OAB ) . Predominant stress insensate incontinence History neurogenic bladder Two urinary tract infection last six month Gastric bypass ( RouxenY ) surgery ( adjustable gastric banding allow ) Donated &gt; 500mL blood 30 day prior screen visit</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>